Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: GDRX stock price vs PNR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PNR's multiple
Needs PNR P/E.
Implied fair value · at GDRX's multiple
Needs GDRX P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GDRX FY 2025 (ended Dec 31, 2025) · PNR FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
GoodRx Holdings, Inc. · implied price per share
Bear
$2.87
Base
$3.38
Bull
$3.88
Pentair plc · implied price per share
Bear
$32.19
Base
$37.87
Bull
$43.55
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.81x
0.42x
Net debt / EBITDA
Leverage against operating earnings
1.26x
1.56x
Cash and equivalents
Liquid reserves on the balance sheet
$261.82M
$82.50M
Total debt
Interest-bearing obligations outstanding
$500.00M
$1.64B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Evolent Health, Inc.
GDRX vs EVH
CVS HEALTH Corp
GDRX vs CVS
Doximity, Inc.
GDRX vs DOCS
Criteo S.A.
GDRX vs CRTO
WATTS WATER TECHNOLOGIES INC
GDRX vs WTS
SMITH A O CORP
GDRX vs AOS
Ingersoll Rand Inc.
GDRX vs IR
Xylem Inc.
GDRX vs XYL
EMERSON ELECTRIC CO
GDRX vs EMR
IDEX CORP /DE/
GDRX vs IEX
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe GDRX can materially improve margins and stabilize financial quality from today’s weak 0.53 Altman Z-Score, then the shares may deserve a higher multiple; otherwise, the current 33.9x P/E and -42.8% implied downside argue for caution versus PNR.
GDRX trades at 33.9x P/E versus 19.4x for PNR, yet the implied price is $1.74, or 42.8% below the current $3.05. The relative discount is driven more by GDRX's lower operating quality and weaker balance-sheet signals than by superior growth or margins.
Supporting Metrics
